Can macrolide antibiotics prevent hospital readmissions?
File(s)rccm.201905-0957ed.pdf (483.49 KB)
Published version
Author(s)
Wedzicha, Jadwiga A
Ritchie, Andrew I
Martinez, Fernando J
Type
Journal Article
Date Issued
2019-10-01
Date Acceptance
2019-06-11
Citation
American Journal of Respiratory and Critical Care Medicine, 2019, 200 (7), pp.796-798
ISSN
1073-449X
Publisher
American Thoracic Society
Start Page
796
End Page
798
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
200
Issue
7
Copyright Statement
© 2019 American Thoracic Society, All Rights Reserved. This article is open access and distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives License 4.0
(http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage
and reprints, please contact Diane Gern (dgern@thoracic.org).
Commons Attribution Non-Commercial No Derivatives License 4.0
(http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage
and reprints, please contact Diane Gern (dgern@thoracic.org).
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31188635
Subjects
Science & Technology
Life Sciences & Biomedicine
Critical Care Medicine
Respiratory System
General & Internal Medicine
OBSTRUCTIVE PULMONARY-DISEASE
DOUBLE-BLIND
ACUTE EXACERBATIONS
CONTROLLED-TRIAL
AZITHROMYCIN
RECOVERY
COPD
Anti-Bacterial Agents
Azithromycin
Double-Blind Method
Hospitalization
Humans
Macrolides
Patient Readmission
Pulmonary Disease, Chronic Obstructive
Humans
Pulmonary Disease, Chronic Obstructive
Macrolides
Azithromycin
Anti-Bacterial Agents
Hospitalization
Patient Readmission
Double-Blind Method
Respiratory System
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2019-10-01